With each weekly injection, youll attach a new needle to your semaglutide pen and dial to select your dose
Support from the European the Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 279153 (Beta-JUDO), the Regional Research Council in Uppsala-rebro, Sweden, the Swedish Diabetes Foundation, the Swedish Society for Diabetology, the Gillbergska Foundation, Swedish Research Council (2016-01040), and AstraZeneca was received for the study
Hsieh, M
Protein & Cell2018, 9, 3346
Transparency with your provider regarding any symptoms is vital to ensure continued Tirzepatide safety
This article explains the dosing framework from Phase 2 trial data, administration guidance, and key safety considerations